sydneyrx2014.com Available ED Drugstore is an 1st. pharmacy providing a individual service to the society in Australia. Over 80,000 extremely satisfied buyers! We're your medication drug store levitra australia and have provided trusted service to families in Australia for over 15 years.

англ., 10.02.14

PACKAGE LEAFLET FOR USE
Tobraculin-D eye drops, suspension for dogs and cats NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
AND OF THE MANUFACTURING AUTHORISATION HOLDER, IF
DIFFERENT
NAME OF THE VETERINARY MEDICINAL PRODUCT
Tobraculin-D eye drops, suspension for dogs and cats STATEMENT
SUBSTANCE(S)
INGREDIENT(S)
1 ml of the suspension contains 3 mg of tobramycin (as sulphate) and 1 mg of Excipients: benzalkonium chloride, disodium edetate, potassium dihydrogen phosphate, disodium phosphate dodecahydrate, sodium chloride, polysorbate 80, hydroxyethylcellulose, INDICATIONS
The product is used in inflammatory conditions of the conjunctiva, cornea and anterior chamber of the eye, where the use of corticosteroids is recommended and there is a risk of or an existing superficial bacterial infection – conjunctivitis, keratitis, keratoconjunctivitis, blepharitis, blepharoconjunctivitis, hordeolum, dacrocystitis, iritis, after extraction of foreign bodies from the cornea and conjunctiva; preoperatively and postoperatively, in extra- and intrabulbar operations in dogs and cats. CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substances or to any of the excipients. Do not use in viral and fungal infections of the eyes. Do not use other eye drops or ointments ADVERSE REACTIONS
Serious adverse effects from the use of Tobraculin-D have not been observed. Burning, itching and swelling of the eyelids, photophobia or conjunctival erythema are likely to occur. In such cases, the administration of the product should be discontinued. With prolonged use of the product, disbacteriosis with overgrowth of microorganisms, non- susceptible to tobramycin, including fungi, is likely to occur. In such cases, appropriate treatment should be instituted. Delayed healing of ocular defects and an increase of the If you notice any serious effects or other effects resulting from the use of this veterinary medicinal product, not mentioned in this package leaflet, please inform immediately your TARGET SPECIES
SPECIES,
ROUTE(S)
ADMINISTRATION
Method of administration:
Shake the vial vigorously before use. Apply by instilling into the lower conjunctival sac, taking care to avoid the contact betwen the dropper applicator and the eye and the skin of the hands. After each instillation, the inner corner of the eye is pressed for about 30-60 seconds, in order to prevent a leakage of the suspension through the lacrimal ducts. Usually, 1-2 drops are instilled every 4-6 hours. In acute inflammation, the treatment can be initiated with 1-2 drops every 2 hours for the first 24-48 hours, and gradually, along with improvement of the clinical symptoms, be switched to a regime of 1-2 drops every 4-6 hours. ADVICE ON CORRECT ADMINISTRATION
When handling the product, care should be taken for contamination of the skin of the hands, 10. WITHDRAWAL PERIOD
11. SPECIAL STORAGE PRECAUTIONS
Store in a dry place. Protect from direct sunlight. Shelf-life after first opening the vial: 28 days at a temperature below 25° С. 12. SPECIAL WARNING(S)
13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR
WASTE MATERIALS, IF ANY
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements. 14. DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED
15. OTHER INFORMATION
White plastic vials containing 5 ml, fitted with a dropper applicator and closed with a screw

Source: http://antibiotic.bg/uploads//7bc8d57e1d8436a9ead4e033b970c81ca7c6b75f.pdf

Forschungsgemeinschaft funk e.v. / online-artikel: reviews + literaturzitate

Dr. rer. nat. Frank GollnickForschungsgemeinschaft FunkJuutilainen, 1997: Juutilainen J, Lang S: “Genotoxic, carcinogenic and teratogenic effects of electromagnetic fields. Introduction and overview” in: Mutat Res 1997; 387 (3): 165 - 171Brusick, 1998: Brusick D, Albertini R, Mc Ree D, Peterson D, Williams G, Hanawalt P, Preston J: “Genotoxicity of radiofrequency radiation. DNA/Genetox Exp

anfitech.com.br

Product Name ANFITECH BIOTIN Synthetic Antibody Aptamer specific for Rat Brain Tumor Microvessels Concentration 2 mg/ml Synonymns High affinity Oligonucleotide specific for Rat Brain Tumor Microvessels Background Neoangiogenesis, the new formation of blood vessels is associated with endothelial cell proliferation, migration, and formation of new capillaries as a response to t

Copyright © 2010-2014 Pdf Medical Search